Your search returned 1550 results.

Results
	1001.	Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patients. [electronic resource] by Castelli-Haley, Jane Oleen-Burkey, MerriKay Oleen-Burkey, Merry-Kay A Lage, Maureen J Johnson, Kenneth P Producer: 20090106 In: Advances in therapy vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1002.	Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions. [electronic resource] by Saida, Takahiko Itoyama, Yasuto Tashiro, Kunio Kira, Jun-Ichi Hao, Qi Producer: 20130521 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1003.	Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. [electronic resource] by Røsjø, Egil Myhr, Kjell-Morten Løken-Amsrud, Kristin I Bakke, Søren J Beiske, Antonie G Bjerve, Kristian S Hovdal, Harald Lilleås, Finn Midgard, Rune Pedersen, Tom Šaltytė Benth, Jūratė Torkildsen, Øivind Wergeland, Stig Michelsen, Annika E Aukrust, Pål Ueland, Thor Holmøy, Trygve Producer: 20150512 In: Journal of neuroimmunology vol. 280 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1004.	Safety and effectiveness of interferon β-1a intramuscular therapy: results of the postmarketing drug surveillance in Japan. [electronic resource] by Makioka, Haruki Nakaya, Fuyuki Ling, Yan Torii, Shinichi Saida, Takahiko Kira, Jun-Ichi Producer: 20180103 In: Rinsho shinkeigaku = Clinical neurology vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1005.	Differential induction of 2',5'-oligoadenylate synthetase by IFN-beta ser and IFN-alpha 2 in serum-supplemented and serum-free HL-60 leukemic cell cultures. [electronic resource] by Fraioli, M Wu, J M Producer: 19900322 In: Journal of biological regulators and homeostatic agents vol. 3 Availability: No items available. Save to lists Add to cart (remove)
	1006.	Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons. [electronic resource] by Vita, J R Edwalds, G M Gorey, T Housepian, E M Fetell, M R Guarini, L Langer, J A Fisher, P B Producer: 19880802 In: Anticancer research vol. 8 Availability: No items available. Save to lists Add to cart (remove)
	1007.	[Interferon-beta in treatment of relapsing multiple sclerosis]. [electronic resource] by Hartung, H P Hohlfeld, R Producer: 19940526 In: Der Nervenarzt vol. 65 Availability: No items available. Save to lists Add to cart (remove)
	1008.	Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-1b in relapsing-remitting MS. [electronic resource] by Río, J Nos, C Marzo, M E Tintoré, M Montalban, X Producer: 19980709 In: Neurology vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1009.	Double-blind randomized multicenter dose-comparison study of interferon-beta-1a (AVONEX): rationale, design and baseline data. [electronic resource] Producer: 20011212 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1010.	Current status of multiple sclerosis therapy in Germany: a national survey. [electronic resource] by Heesen, C Hauer, S Hadji-Abdolrahim, B Berenbeck, C Buhmann, C Emskotter, T Producer: 20000606 In: European journal of neurology vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1011.	[Correction of autonomic sensory disorders in middle ear diseases]. [electronic resource] by Morozova, S V Zaĭtseva, O V Producer: 20021023 In: Vestnik otorinolaringologii no. 3 Availability: No items available. Save to lists Add to cart (remove)
	1012.	Therapeutic approaches to secondary progressive multiple sclerosis. [electronic resource] by Lublin, F D Producer: 20021016 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1013.	Mx proteins in blood leukocytes for monitoring interferon beta-1b therapy in patients with MS. [electronic resource] by Kracke, A von Wussow, P Al-Masri, A N Dalley, G Windhagen, A Heidenreich, F Producer: 20000127 In: Neurology vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1014.	Extended observations on MS patients treated with IM interferon-beta1a (Avonex): implications for modern MS trials and therapeutics. [electronic resource] by Jacobs, L Rudick, R Simon, J Producer: 20000727 In: Journal of neuroimmunology vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1015.	Effects of interferon beta-1a and -1b over time: 6-year results of an observational head-to-head study. [electronic resource] by Patti, F Pappalardo, A Florio, C Politi, G Fiorilla, T Reggio, E Reggio, A Producer: 20060518 In: Acta neurologica Scandinavica vol. 113 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1016.	Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg. [electronic resource] by Rüegg, Stephan J Fuhr, Peter Steck, Andreas J Producer: 20050804 In: Neurology vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1017.	Immunogenicity and tolerability of an investigational formulation of interferon-beta1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis. [electronic resource] by Giovannoni, Gavin Barbarash, Olga Casset-Semanaz, Florence Jaber, Amer King, John Metz, Luanne Pardo, Gabriel Simsarian, James Sørensen, Per Soelberg Stubinski, Bettina Producer: 20070925 In: Clinical therapeutics vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1018.	Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis. [electronic resource] by Vandenbark, Arthur A Huan, Jianya Agotsch, Marisa La Tocha, Dorian Goelz, Susan Offner, Halina Lanker, Stefan Bourdette, Dennis Producer: 20091109 In: Journal of neuroimmunology vol. 215 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1019.	Adherence to multiple sclerosis disease-modifying therapies in Ontario is low. [electronic resource] by Wong, Janice Gomes, Tara Mamdani, Muhammad Manno, Michael O'Connor, Paul W Producer: 20110803 In: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1020.	Management of optic neuritis. [electronic resource] by Menon, Vimla Saxena, Rohit Misra, Ruby Phuljhele, Swati Producer: 20110615 In: Indian journal of ophthalmology vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1550 results.